Regulatory26 May 2026, 07:41 pm
JHS Svendgaard: Deviation Statement for March 2026 Quarter
AI Summary
JHS Svendgaard Laboratories Ltd has filed a statement of deviation for the quarter ended March 31, 2026, regarding the utilization of funds raised through a preferential issue. The Board of Directors approved this statement on May 26, 2026. According to the filing, there was no deviation or variation in the use of funds raised. The funds were raised on June 4, 2024, amounting to ₹29.99 crores.
Key Highlights
- JHS Svendgaard reports no deviation in the use of funds raised through preferential issue.
- Funds raised via preferential issue on June 4, 2024, totaled ₹29.99 crores.
- The deviation statement pertains to the quarter ended March 31, 2026.
- Original allocation was for setting up a new project in Jammu & Kashmir and for general corporate purposes.
Price Impact
More from JHS